Clincosm LogoSign in Get a demo

recurrent breast cancer

Showing 1 - 25 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

Active, not recruiting
  • HER2-positive Breast Cancer
  • +9 more
  • pertuzumab
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Circulating miRNAs.

Completed
  • Breast Cancer
  • +2 more
    • Cork, Ireland
    • +6 more
    Jan 4, 2022

    Treating Patients With Stage IV Breast Cancer

    Active, not recruiting
    • Central Nervous System Metastases
    • +15 more
    • hyperfractionated radiation therapy
    • +2 more
    • North Chicago, Illinois
      University of Chicago
    Dec 6, 2021

    Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

    Completed
    Has Results
    • Breast Cancer
    • +2 more
    • Radiation
    • +2 more
    • New York, New York
      New York University Medical Center
    Oct 25, 2021

    Comprehensive Gene Sequencing in Guiding Treatment

    Completed
    • Recurrent Breast Cancer
    • +7 more
    • cytology specimen collection procedure
    • laboratory biomarker analysis
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Oct 21, 2021

    Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Belgium, Denmark, Spain (ModraDoc006/r)

    Completed
    • Metastatic Breast Cancer
    • Recurrent Breast Cancer
    • Brussels, Belgium
    • +3 more
    Oct 18, 2021

    HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Los Angeles (drug, biological, other)

    Terminated
    • HER2-positive Breast Cancer
    • +2 more
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    Aug 22, 2021

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Puerto Rico,

    Active, not recruiting
    • Estrogen Receptor-positive Breast Cancer
    • +8 more
    • Birmingham, Alabama
    • +859 more
    Jul 19, 2021

    Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Boston (Ruxolitinib, Paclitaxel)

    Completed
    Has Results
    • Recurrent Breast Cancer
    • Metastatic Breast Cancer
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 26, 2021

    Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer Trial in Orange (Carboplatin, paclitaxel

    Active, not recruiting
    • Breast Cancer
    • +9 more
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Apr 14, 2021

    Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

    Completed
    Has Results
    • Adult Solid Tumor
    • +38 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    Feb 18, 2021

    Anxiety Disorder, Depression, Recurrent Breast Cancer Trial in Columbus (minocycline HCl, , laboratory biomarker analysis)

    Active, not recruiting
    • Anxiety Disorder
    • +8 more
    • minocycline hydrochloride
    • +3 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Jan 14, 2021

    Abbreviated Breast MRI for Second Breast Cancer Detection in

    Recruiting
    • Breast Cancer
    • +4 more
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Nov 26, 2020

      Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications Trial in Los Angeles (mucoadhesive

      Completed
      • Estrogen Receptor-positive Breast Cancer
      • +7 more
      • mucoadhesive oral wound rinse
      • laboratory biomarker analysis
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center
      Sep 17, 2020

      Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Richmond (Experimental Arm A: Pemetrexed, Experimental

      Terminated
      Has Results
      • Breast Cancer
      • +2 more
      • Experimental Arm A: Pemetrexed
      • +3 more
      • Richmond, Virginia
        Virginia Commonwealth University/Massey Cancer Center
      Jun 30, 2020

      HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago (drug, biological, other)

      Completed
      Has Results
      • HER2-positive Breast Cancer
      • +5 more
      • PI3K inhibitor BYL719
      • +3 more
      • Chicago, Illinois
        Northwestern University
      Jun 25, 2020

      Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Columbus (dietary supplement, other, procedure)

      Unknown status
      • Recurrent Breast Cancer
      • +6 more
      • omega-3 fatty acid supplement
      • +5 more
      • Columbus, Ohio
        Ohio State University Medical Center
      Jun 3, 2020

      Breast Cancer, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Philadelphia (acupuncture therapy, sham intervention)

      Completed
      • Breast Cancer
      • +6 more
      • acupuncture therapy
      • sham intervention
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of The University of Pennsylvania
      Apr 7, 2020